Nathan completed his B.S. in Chemistry at the University of California, Santa Barbara. Here, he worked under the supervision of Prof. Bazan on the synthesis and testing of novel antibiotic derivatives. While at UCSB, he also interned in Prof. Corradin's lab at the CHUV in Switzerland where he synthesized and tested peptide-based vaccine candidates for Malaria and COVID-19. After completing the 1st year of his PhD at UCLA where he synthesized OFCP-macrobicyles, Nathan joined both the Conway group and Houk lab and switched his focus to computational medicinal chemistry. For his thesis, he is using molecular dynamic simulations to design selective Bromodomain ligands for S. mansoni BRD3(BD2).